Hepion Pharmaceuticals, Inc. — Form D

Hepion Pharmaceuticals, Inc. of RED BANK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-15. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Gary S JacobsDirectorEdison, NJ
Arnold P LippaDirectorEdison, NJ
Todd HobbsExecutive OfficerEdison, NJ
Sireesh AppajosyulaRelated PersonRed Bank, NJ
Gary StetzRelated PersonRed Bank, NJ
Vincent LoPrioreRelated PersonRed Bank, NJ
Robert FosterDirectorWaverly, OH
Robert FosterExecutive OfficerWaverly, OH
James SapirsteinDirectorCincinnati, OH
James SapirsteinExecutive OfficerCincinnati, OH
Kaouthar P LbiatiDirectorEdison, NJ
John CavanExecutive OfficerEdison, NJ
Michael P PurcellDirectorEdison, NJ
Timothy P BlockDirectorEdison, NJ
Anand ReddiDirectorEdison, NJ
Petrus P WijngaardDirectorEdison, NJ
Gary JacobDirectorSan Diego, CA
John BrancaccioDirectorSan Diego, CA
Thomas P AdamsDirectorEdison, NJ
John P CavanExecutive OfficerEdison, NJ
John P BrancaccioDirectorNew Hope, PA
Bill HornungExecutive OfficerEdison, NJ
Timothy BlockDirectorRed Bank, NJ
Timothy BlockRelated PersonRed Bank, NJ
Christopher McGuiganDirectorEdison, NJ

Other filings by this issuer (8)

FiledFormOfferingSold
2026-08-05D$3.1M$3.1M
2026-04-22D$700K$700K
2024-07-24D$2.9M$2.9M
2023-10-03D$5.0M$5.0M
2019-03-27D$1.3M$1.3M
2014-10-23D$12.5M$9.0M
2014-08-22D$4.7M$4.7M
2014-02-14D$3.2M$3.2M

More